RiverFront Investment Group’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-38,919
| Closed | -$896K | – | 134 |
|
|
2023
Q4 | $896K | Sell |
38,919
-2,127
| -5% | -$48.9K | 0.03% | 86 |
|
|
2023
Q3 | $835K | Sell |
41,046
-1,408
| -3% | -$28.7K | 0.03% | 84 |
|
|
2023
Q2 | $991K | Sell |
42,454
-1,190
| -3% | -$27.8K | 0.03% | 82 |
|
|
2023
Q1 | $1.02M | Sell |
43,644
-1,958
| -4% | -$45.6K | 0.04% | 79 |
|
|
2022
Q4 | $1.15M | Buy |
45,602
+22,334
| +96% | +$562K | 0.26% | 68 |
|
|
2022
Q3 | $614K | Sell |
23,268
-1,057
| -4% | -$27.9K | 0.02% | 74 |
|
|
2022
Q2 | $703K | Sell |
24,325
-69
| -0.3% | -$1.99K | 0.03% | 77 |
|
|
2022
Q1 | $840K | Buy |
24,394
+11,552
| +90% | +$398K | 0.03% | 77 |
|
|
2021
Q4 | $563K | Buy |
+12,842
| New | +$563K | 0.02% | 79 |
|